Industry News
Resolian acquires China-based bioanalytical CRO Denali Medpharma
Resolian can now initiate projects on four continents and easily transfer validated methods across labs
Resolian can now initiate projects on four continents and easily transfer validated methods across labs
Deborah McManus and Gareth Satchell, Drug Development Solutions, LGC
Guest editorial by Kim James, Solid Form Expert, LGC Drug Development Solutions
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
Specific cross functional expertise in impurity analysis and contamination investigations
The acquisition of Toronto Research Chemicals brings wide breadth of synthetic and analytical chemistry capabilities